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Abstract:  Sydenham chorea is a 
major manifestation of Rheumatic 
fever (RF). Chorea occurs primar-
ily in children and is rare after the 
age of 20 years. Females are more 
often affected and it almost never 
occurs in post-pubertal males. 
Sydenham’s chorea is character-
ized by emotional lability, unco-
ordinated and erratic movements, 
and muscular weakness. The 
choreiform movements can be a 
source of irritation or a severe 
functional disability to the individ-
ual requiring appropriate manage-
ment. The rarity of documentation 
of SC in sub-Saharan Africa raises 
the possibility of missed or misdi-
agnosis. We present the case of a 
13 year old girl whose SC was 
initially misdiagnosed and con-
clude that though uncommon in 
Sub-Saharan Africa, SC requires 





Chorea has been defined as a state of excessive, sponta-
neous movements, irregularly timed, non-repetitive, 
randomly distributed and abrupt in character. These 
movements may vary in severity from restlessness with
mild intermittent exaggeration of gesture and expres-
sion, fidgeting movements of the hands, unstable dance-
like gait to a continuous flow of disabling, violent move-
ments1. Sydenham’s chorea was first described by Tho-
mas Sydenham in 1684 as a clinical syndrome2 and its 
link to rheumatic fever was proposed by Stoll in 17802. 
Since then, Chorea has been recognized as a major 
manifestation of acute Rheumatic Fever (ARF) and may
be the only evidence in approximately 20% of cases2. 
Chorea occurs primarily in female children. The preva-
lence of chorea in patients with RF varies from 5–36% 
in different reports3. The incidence in Africa is not pre-
cisely known but one pooled study has put it at 8.8%4  
Incidence of ARF is decreasing in almost all the WHO 
Regions of the world4, and as such Sydenham’s chorea 
is also decreasing4.  Currently, younger doctors may 
have never seen a patient with rheumatic chorea and 
have become unfamiliar with the disease. We report the 
case of a 13-year-old girl, who presented in our clinic 
with acute onset of abnormal involuntary movements 




OA is a 13 year old girl who presented at the Paediatrics 
clinic of Reddington Hospital, Lagos, Nigeria with a 
three day history of rhythmic and involuntary jerking of 
the hands and five months history of joint pains. 
She was well until five months previously when she 
developed severe pains on her right knee which was 
managed with topical analgesics and bandaging. Three 
weeks later she experienced similar pains in her left 
knee and then the left elbow. There was no history of 
joint swellings. 
Three days before presentation, she developed twitching 
and involuntary jerking of her upper limbs and face. The 
jerky movements worsened whenever she became agi-
tated and tried to stop them but disappears while asl ep. 
The abnormal movements made her very anxious and 
self-conscious. 
She was taken to a hospital where a diagnosis of upper 
limb dystonia was made and was commenced on Artane 
(Trihexyphenidyl). She was brought to our facility the 
next day because the jerking persisted.  
 
General examination was normal except that she looked 
anxious with intermittent, involuntary jerks of both up-
per limbs and facial twitches. The twitches were subtle 
and the involuntary jerks consisted of fidgeting move-
ments of the upper limbs which occurred every few min-
utes and were of very low amplitude, though she re-
ported occasional involuntary flinging of her arms. She 
was lucid and had age-appropriate mentality. Both hands 
were not able to sustain a strong grip (milkmaid hand). 
Her knees revealed no signs of inflammation. Both 
knees demonstrated crepitus. Her respiratory and cardio-
vascular systems were normal on physical examinatio.  
Full blood count done at presentation showed slight neu-
trophilia(78%) and elevated erythrocyte sedimentation 
rate of 43mm/hr (Reference range 0-10mm/hr ). The 
throat swab culture yielded no growth but anti-
streptolysin O-titre (ASOT) was elevated at 420IU 
(Reference range <200 I.U). Electrocardiogram, echo-
cardiogram and electroencephalogram showed normal 
findings. Antineuronal Antibody (ANA) titre was posi-
tive but DNAse B titre was negative. 
A diagnosis of Sydenham’s chorea (SC) was made. She 
was commenced on Sodium Valproate, Ibuprofen and 
Penicillin V. These medications were given respectiv ly 
to control the involuntary movements, reduce pain and
inflammation of the joints and eliminate any streptococ-
cal organism remaining in her system. The patient’s 
condition improved within 48 hours. By the second 
week, the involuntary movements had disappeared. The 
patient has resumed normal activities and has been fol-
lowed up in our clinics for about 8 months. No recur-





Reliable data on the incidence of SC and RF are scarce. 
The incidence of SC in Africa is not known but one 
pooled study has put it at 8.8%4. No known data exists 
for SC in Nigeria but Okoroma et al5 in Enugu reported 
it as being rare in their study. The diagnosis of SC de-
pends on a high index of suspicion. Depending on the 
experience of the health provider the diagnosis maybe 
entirely missed due to lack of awareness of the clinical 
entity. Our patient presented early to a peripheral hospi-
tal where the diagnosis was missed delaying manage-
ment of her rheumatic chorea.  
Considering the high contribution of RHD to acquired 
heart disease in Sub-Saharan Africa6,7, the low incidence 
of SC appears paradoxical and the explanation is not 
clear. Studies of ARF outbreak in the USA during the
1990’s attributed SC to highly virulent mucoid strains of 
group A Streptococci8. Though, it may be attractive to 
speculate that the strains of group A Streptoccoci in our 
environment are less virulent and therefore have lower 
propensity for causing SC, further studies need to be 
done on the virulence and immunogenicity of the strains 
of group A Streptoccoci in our environment that cause 
ARF to establish that.  
 
According to Jones criteria4 chorea alone is sufficient 
for diagnosis of RF4 provided other causes of chorea had 
been excluded. Other possible causes of childhood ch -
rea include cerebrovascular accidents, collagen vascul r 
diseases, drug intoxication, hyperthyroidism, Wilson'  
disease, Huntington's disease, abetalipoproteinemia, 
Lesch-Nyhan syndrome and hormonal imbalances2. 
Unlike SC, Huntington chorea is generally a  
disease of adult onset with an unremitting autosomal 
dominant movement disorder and dementia; unlike in 
Huntington disease, neuroimaging in Sydenham's chorea 
is normal and other family members are usually unaf-
fected. Our patient manifested the main features of SC 
as listed by WHO2 viz: involuntary movements, hypoto-
nia, and muscular weakness. Chorea can be generalized 
or unilateral2. Patients with SC may also have psychiat-
ric symptoms such as depression, anxiety, personality 
changes, etc7 Whether the psychological manifestations 
are secondary to the movement disorder or an integral 
part of the disease is not clear. It is also common for 
some patients with SC to present with other manifesta-
tions of RF2. Our patient had chronic arthralgia but had 
no clinical evidence of carditis. This may not be unusual 
as carditis has been documented to occur in only about 
40-50% of patients with ARF at the time of diagnosis9. 
Averagely, rheumatic chorea resolves spontaneously 
within 3-6 months but may last longer if untreated. With 
treatment our patient’s symptoms resolved within two 
weeks. Fast resolution with treatment has also been r -
ported by other researchers4,6,7. About 20% of patients 
may experience recurrences and relapses, usually within 
2 years after the initial attack7 and this underscores the 
need for adequate follow up. 
Treatment of SC is typically limited to supportive care, 
palliative medications, to eliminate streptococci and 





Sydenham’s chorea is a disabling manifestation of rheu-
matic fever, and its rarity in sub-Saharan Africa my 
have contributed to cases being misdiagnosed or even
missed. It requires proper diagnosis as prompt and ap-
propriate medications can bring quick resolution to 
symptoms. There is need for continual awareness crea-
tion on manifestations of ARF and its proper manage-
ments. 
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